Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis

Liver International

Volumn 36, Issue 9, 2016, Pages 1370-1377

  Zweers, Serge J ^a   Shiryaev, Alexey ^b,c   Komuta, Mina ^d   Vesterhus, Mette ^b,e   Hov, Johannes R ^b,c,f   Perugorria, María J ^g   de Waart, D Rudi ^a   Chang, Jung Chin ^a   Tol, Shanna ^a   te Velde, Anje A ^a   de Jonge, Wouter J ^a   Banales, Jesus M ^g   Roskams, Tania ^d   Beuers, Ulrich ^a   Karlsen, Tom H ^b,c,f   Jansen, Peter L ^a,h   Schaap, Frank G ^a,h  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g HOSPITAL DONOSTIA   (Spain)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

bile; gallbladder; interleukin 8; primary sclerosing cholangitis

Indexed keywords

BILE SALT; BILIRUBIN; CHOLESTEROL; FIBROBLAST GROWTH FACTOR 19; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; IL8 PROTEIN, HUMAN;

ARTICLE; BILE DUCT; BILE LEVEL; CELL PROLIFERATION; CELLS BY BODY ANATOMY; CHOLANGIOCYTE; CHOLESTEROL BILE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IN VITRO STUDY; LIPID BILE LEVEL; LIVER TRANSPLANTATION; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN LOCALIZATION; ADULT; AGED; BILE; CHEMISTRY; FEMALE; GENETICS; HEPATOBILIARY SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; NORWAY; PATHOLOGY; SCLEROSING CHOLANGITIS;

ADULT; AGED; BILE; BILIARY TRACT; CELL PROLIFERATION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NORWAY; RNA, MESSENGER;

EID: 84960968095     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.13092     Document Type: Article

References (30)

1. Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet 2013; 382: 1587–99.
2. Thorpe ME, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut 1967; 8: 435–48.
3. Folseraas T, Liaskou E, Anderson CA, Karlsen TH. Genetics in PSC: what do the “risk genes” teach us? Clin Rev Allergy Immunol 2015; 48: 154–64.
4. Boonstra K, de Vries EM, van Geloven N, et al. Risk factors for Primary Sclerosing Cholangitis. Liver Int 2016; 36: 84–91.
5. Liaskou E, Jeffery LE, Trivedi PJ, et al. Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. Gastroenterology 2014; 147:221–32 e7.
6. Karrar A, Broome U, Sodergren T, et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 2007; 132: 1504–14.
7. Mueller T, Beutler C, Pico AH, et al. Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis. Liver Int 2011; 31: 1574–88.
8. Zweers SJ, Booij KA, Komuta M, et al. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology 2012; 55: 575–83.
9. Drafahl KA, McAndrew CW, Meyer AN, Haas M, Donoghue DJ. The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling. PLoS ONE 2010; 5: e14412.
10. Banales JM, Saez E, Uriz M, et al. Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 2012; 56: 687–97.
11. Urribarri AD, Munoz-Garrido P, Perugorria MJ, et al. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases. Gut 2014; 63: 1658–67.
12. van de Steeg E, Wagenaar E, van der Kruijssen CM, et al. Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest 2010; 120: 2942–52.
13. Kunne C, Acco A, Hohenester S, et al. Defective bile salt biosynthesis and hydroxylation in mice with reduced cytochrome P450 activity. Hepatology 2013; 57: 1509–17.
14. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989; 30: 719–30.
15. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121–7.
16. Palter SF, Mulayim N, Senturk L, Arici A. Interleukin-8 in the human fallopian tube. J Clin Endocrinol Metab 2001; 86: 2660–7.
17. Isse K, Harada K, Nakanuma Y. IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules. Liver Int 2007; 27: 672–80.
18. Yokoyama T, Komori A, Nakamura M, et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int 2006; 26: 467–76.
19. Morland CM, Fear J, Joplin R, Adams DH. Inflammatory cytokines stimulate human biliary epithelial cells to express interleukin-8 and monocyte chemotactic protein-1. Biochem Soc Trans 1997; 25: 232S.
20. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 2001; 12: 375–91.
21. Dong R, Zheng S. Interleukin-8: a critical chemokine in biliary atresia. J Gastroenterol Hepatol 2015; 30: 970–6.
22. Ghasemi H, Ghazanfari T, Yaraee R, Faghihzadeh S, Hassan ZM. Roles of IL-8 in ocular inflammations: a review. Ocul Immunol Inflamm 2011; 19: 401–12.
23. Zimmermann HW, Seidler S, Gassler N, et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS ONE 2011; 6: e21381.
24. Ma HD, Wang YH, Chang C, Gershwin ME, Lian ZX. The intestinal microbiota and microenvironment in liver. Autoimmun Rev 2015; 14: 183–91.
25. Syal G, Fausther M, Dranoff JA. Advances in cholangiocyte immunobiology. Am J Physiol Gastrointest Liver Physiol 2012; 303: G1077–86.
26. Tabibian JH, O'Hara SP, Splinter PL, Trussoni CE, LaRusso NF. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis. Hepatology 2014; 59: 2263–75.
27. Clement S, Pascarella S, Conzelmann S, et al. The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8. J Hepatol 2010; 52: 635–43.
28. Langhans B, Kramer B, Louis M, et al. Intrahepatic IL-8 producing Foxp3(+)CD4(+) regulatory T cells and fibrogenesis in chronic hepatitis C. J Hepatol 2013; 59: 229–35.
29. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000; 72: 391–8.
30. Amura CR, Brodsky KS, Gitomer B, et al. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation. Am J Physiol Cell Physiol 2008; 294: C786–96.